The Atrial Fibrillation Drugs Market is projected to expand from US$ 18.06 Billion in 2025 to US$ 26.14 Billion by 2034, registering a CAGR of 4.19% during 2026–2034. The market is expanding as the prevalence of atrial fibrillation increases among aging populations and healthcare systems place greater emphasis on reducing stroke and cardiovascular complications...